You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What is the recommended vascepa dosage for adults?

See the DrugPatentWatch profile for vascepa

The recommended dosage of Vascepa for adults is 2 grams per day, taken as two 1 gram capsules, once daily with food [1]. It is important to follow the dosage prescribed by a healthcare professional. Vascepa is a prescription medication used to lower triglyceride levels in adult patients [1]. It is a formulation of the omega-3 fatty acid, icosapent ethyl [1].

It is worth noting that, according to the drug's official website, "Vascepa (icosapent ethyl) capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia" [1].

Regarding the drug's patent status, as per DrugPatentWatch.com, Vascepa's patent expired in December 2020 [2]. However, the specific impact of this event on the drug's availability, pricing, or dosage is not provided.

In conclusion, the recommended dosage of Vascepa for adults is 2 grams per day, taken as two 1 gram capsules, once daily with food. Any changes to the dosage should be discussed with a healthcare professional.

Sources:
[1] Vascepa (icosapent ethyl) capsules, for oral use. Full Prescribing Information. Amarin Pharma, Inc.; 2021. Available from: <https://www.vascepa.com/sites/default/files/Vascepa-PI-2021-02-22.pdf>.
[2] DrugPatentWatch. Vascepa (Icosapent Ethyl) Drug Patent Expiration Dates. Available from: <https://www.drugpatentwatch.com/drugs/vascepa>.


Other Questions About Vascepa :  How long will the vascepa discount last? Can vascepa and probiotics be taken together? Are there any side effects when taking vascepa with otcs?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy